严重的大动脉狭窄的手术治疗:无或有支架的生物假体大动脉置换
Alessandro Ricasoli1, Carmelo Mignosa1, Salvatore Lentini1
1Cardiac Surgery Unit, University of Catania, 95124 Catania, Italy.
Journal of clinical medicine
|August 28, 2025
概括
与传统的支架式生物假体相比,无支架的Percival S动脉置换提供了更短的手术时间和住院时间. 这种方法使得术后恢复更好,并促进了微创手术.
科学领域:
- 心血管外科
- 生物材料科学
背景情况:
- 严重的大动脉狭窄需要大动脉置换.
- 传统的生物假体通常需要复杂的植入程序.
- 无的生物假体旨在简化植入并改善患者的治疗结果.
研究的目的:
- 为了比较没有接的Perceval S主动脉植入与支架的Carpentier Edwards Perimount生物假体的结果.
- 分析手术期间,手术后和血液动力学参数的差异.
主要方法:
- 在每组37名患者中进行的倾向匹配机构研究.
- 患者进行了大动脉置换,使用的是Perceval S或Carpentier Edwards Perimount假体.
- 收集和分析了手术前,手术期间和手术后的数据.
主要成果:
- 无组 (Perceval S) 的交叉,呼吸,ICU和住院时间显著缩短 (p < 0. 001).
- 在 Perceval S 组中,有效孔径面积显著增加 (1. 5 ± 0. 18 cm2 与 1.1 ± 0. 4 cm2, p = 0. 002).
- 在Perceval S组中,最少入侵的方法更为频繁.
结论:
- 佩尔塞瓦尔S是一种有效的替代性主动脉置换,提供良好的血液动力学.
- 它减少了缺血和体外循环时间,从而改善了术后恢复.
- 佩尔塞瓦尔S植入方便进行微创手术.
更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Aneurysm III: Interprofessional Care
24
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Aortic Regurgitation III: Medical Management
42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42


